Stay ahead of the curve with in-depth coverage of the latest breakthroughs, emerging trends, strategic developments, and transformative innovations shaping the future of healthcare, science, technology, and global business.
June Wrap-up with Approvals Image Credits: Biospace Approvals The FDA recently granted approvals for UroGen and RSV immunization. With the approval, Moderna expands mRNA RSV shot. On 13th June 20...
Orphalan Partners to Donate and Ensure Access to all Communities Image Credits: Wilson Disease Org Announcement Orphalan SA, a pharmaceutical company targeting rare diseases, announced its partne...
FUJIFILM VisualSonics’ Smart Patform for Preclinical Ultrasound Image Credits: Imaging Technology News Announcement FUJIFILM VisualSonics Inc., popular in photoacoustic imaging systems and ...
Pendopharm® and Kalvista® Collaborate to Broaden Treatment in Canada Image Credits: AInvest Announcement Pendopharm®, a part of Pharmascience Inc., has signed a distribution agreement...
Orano Med’s Expansion in Texas Announcement Orano Group’s subsidiary, Orano Med, expanded its Research and Development center to Plano, Texas (US) the new center, inaugurated to provid...
Avvio’s Certification Marked a New Phase in Global Transformation Image Credits: Avvio Medical Announcement Avvio Medical Inc., a private medical device company focused on treating kidney s...
Evaxion’s New Vaccine Program Image Credits: University of Alberta Announcement Evaxion, a techbio company leading in the development of AI-Immunology powered vaccines, has introduced a new...
Bavarian Nordic’s First of Two Clinical Trials Image Credits: MedWatch Announcement Bavarian Nordic has initiated the first of two clinical trials to contribute to the use and approval of t...
ProFound Therapeutics, in collaboration with Novartis Image Credits: PharmaLive Which New Collaboration is Currently Streaming in the Healthcare Market? ProFound Therapeutics company focused on t...
Riliprubart is Designated as an Orphan Drug in the US Image Credits: Yahoo Finance Announcement The US Food and Drug Administration approved Rilpivirine, positioning it as an orphan drug designat...
Speak with a healthcare analyst about your research, consulting, or platform needs.